| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 81335-77-5 | 咪草煙; 2-[4,5-二氫-4-甲基-4-(1-甲基乙基)-5-氧代-1H-咪唑-2-基]-5-乙基-3-吡啶羧酸 | Imazethapyr; 2-(4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl)-5-ethyl-3-pyridinecarboxylic acid; 5-Ethyl-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)nicotinic acid; Pursuit DG |  | C15H19N3O3 | 詳情 | 供應(yīng)商 |
| 81385-77-5 | 咪草煙; 咪唑乙煙酸; (RS)-5-乙基-2-(4-異丙基-4-甲基-5-氧代-1H-咪唑啉-2-基)煙酸 | Imazethapyr; 5-Ethyl-2-(4-isopropyl-4-methyl-5-oxo-1H-imidazolin-2-yl)nicotinic acid |  | C15H19N3O3 | 詳情 | 供應(yīng)商 |
| 28505-89-7 | N-[3-[[2-(乙酰氧)-乙基](2-氰乙基)氨基]苯基]乙酰胺; N-乙酰氧乙基-N-氰乙基間氨基乙酰苯胺 | N-[3-[[2-(acetyloxy)ethyl](2-cyanoethyl)amino]phenyl]-Acetamide; 3-N-(2'-Acetoxyethyl)-N-(2''-cyanoethyl) aminoacetanilide |  | C15H19N3O3 | 詳情 | 供應(yīng)商 |
| 114715-76-3 | Carbamic acid,N-[(1S,2S)-1-(2-diazoacetyl)-2-methylbutyl]-, phenylmethyl ester; Carbamicacid, [(1S,2S)-1-(diazoacetyl)-2-methylbutyl]-, phenylmethyl ester (9CI); Carbamic acid, [1-(diazoacetyl)-2-methylbutyl]-, phenylmethyl ester,[S-(R*,R*)]- |  | C15H19N3O3 | 詳情 | 供應(yīng)商 | |
| 102123-81-9 | Carbamic acid,N-[(1S)-1-(2-diazoacetyl)-3-methylbutyl]-, phenylmethyl ester; Carbamicacid, [(1S)-1-(diazoacetyl)-3-methylbutyl]-, phenylmethyl ester (9CI); Carbamicacid, [1-(diazoacetyl)-3-methylbutyl]-, phenylmethyl ester, (S)- |  | C15H19N3O3 | 詳情 | 供應(yīng)商 | |
| 28094-25-9 | Carbamic acid,[1-(diazoacetyl)-2-methylbutyl]-, phenylmethyl ester (9CI); (3S,4S)-3-Z-AMINO-1-DIAZO-4-METHYL-2-HEXANONE; N-ALPHA-BENZYLOXYCARBONYL-L-ISOLEUCINYL-DIAZOMETHANE; Z-L-ILE-CHN2 |  | C15H19N3O3 | 詳情 | 供應(yīng)商 | |
| 115313-19-4 | Carbamic acid,N-[(1R)-3-diazo-2-oxo-1-(phenylmethyl)propyl]-, 1,1-dimethylethyl ester; Carbamicacid, [(1R)-3-diazo-2-oxo-1-(phenylmethyl)propyl]-, 1,1-dimethylethyl ester(9CI); Carbamic acid, [3-diazo-2-oxo-1-(phenylmethyl)propyl]-,1,1-dimethylethyl ester, (R)- |  | C15H19N3O3 | 詳情 | 供應(yīng)商 | |
| 98516-75-7 | Pentanamide,2,5-diamino-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-, (S)- (9CI); H-ORN-AMC |  | C15H19N3O3 | 詳情 | 供應(yīng)商 | |
| 172705-52-1 | Urea,N-propyl-N'-(1,2,3,4-tetrahydro-4,4-dimethyl-1,3-dioxo-7-isoquinolinyl)-; BM 50.0466 |  | C15H19N3O3 | 詳情 | 供應(yīng)商 | |
| 112928-41-3 | Urea,N-(1-methylethyl)-N'-(1,2,3,4-tetrahydro-4,4-dimethyl-1,3-dioxo-7-isoquinolinyl)-; BM 50.0334 |  | C15H19N3O3 | 詳情 | 供應(yīng)商 | |
| 81215-72-7 | 1H-[1,2,5]Triazepino[1,2-b]phthalazine-1,5(2H)-dione,3,4,7,12-tetrahydro-3-(2-methoxyethyl)-; NSC 340348 |  | C15H19N3O3 | 詳情 | 供應(yīng)商 | |
| 152366-40-0 | 2-Pyridinecarboxylicacid,3-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-5-ethyl-; CL 303135 |  | C15H19N3O3 | 詳情 | 供應(yīng)商 | |
| 105891-72-3 | 2,4(3H,5H)-Pyrimidinedione,5,5-diethyl-6-[(3-methoxyphenyl)amino]- |  | C15H19N3O3 | 詳情 | 供應(yīng)商 | |
| 87215-90-5 | 2,4(3H,5H)-Pyrimidinedione,5,5-diethyl-6-[(4-methoxyphenyl)amino]-; 2,4(3H,5H)-Pyrimidinedione, 6-((4-methoxyphenyl)amino)-5,5-diethyl- |  | C15H19N3O3 | 詳情 | 供應(yīng)商 | |
| 64377-90-8 | 2(1H)-Phthalazinepropanamide,3,4-dihydro-3-methyl-N-(1-methylethyl)-1,4-dioxo-; NSC 267970 |  | C15H19N3O3 | 詳情 | 供應(yīng)商 | |
| 97720-16-6 | 2,6,7-Trioxabicyclo[2.2.2]octane,1-(4-azidophenyl)-4-(1,1-dimethylethyl)-; 1-(4-azidophenyl)-4-t-butyl-2,6,7-trioxabicyclo(2.2.2)octane |  | C15H19N3O3 | 詳情 | 供應(yīng)商 | |
| 87215-98-3 | 4,6(1H,5H)-Pyrimidinedione,5,5-diethyl-2-[(4-methoxyphenyl)amino]-; 4,6(1H,5H)-Pyrimidinedione, 5,5-diethyl-2-((4-methoxyphenyl)amino)- |  | C15H19N3O3 | 詳情 | 供應(yīng)商 | |
| 106105-05-9 | 4,6(1H,5H)-Pyrimidinedione,5,5-diethyl-2-[(2-methoxyphenyl)amino]- |  | C15H19N3O3 | 詳情 | 供應(yīng)商 | |
| 106105-04-8 | 4,6(1H,5H)-Pyrimidinedione,5,5-diethyl-2-[(3-methoxyphenyl)amino]- |  | C15H19N3O3 | 詳情 | 供應(yīng)商 | |
| 6532-17-8 | 1-[4-(2-HYDROXY-ETHYL)-PIPERAZIN-1-YLMETHYL]-1H-INDOLE-2,3-DIONE |  | C15H19N3O3 | 詳情 | 供應(yīng)商 | |